Biotec Pharmacon ASA
Cutting-edge biotechnology from Norway — Biotec Pharmacon.
Launch date
Employees
Market cap
€73.5m
Enterprise valuation
€54m (Public information from Sep 2024)
Share price
€1.446 B4V.F
Norway (HQ)
Authorizing premium user...